News

Modifiable Lifestyle Factors: Lipid Levels

27 August 2020

Australian experts have teamed up with MS Research Australia to build an evidence-based lifestyle guide to help people living with the chronic neurological condition multiple sclerosis (MS) improve their disease outcomes by making changes to daily habits.

In this series we take a closer look at nine lifestyle areas and how they may impact those living with MS.

On this episode, Associate Professor Ingrid van der Mei discusses how having abnormal lipid levels might be associated with disability progression.

‘Adapting Your Lifestyle: A Guide for People with MS’ is available on our website here: https://msra.org.au/modifiable-lifestyle-guide-2020/for-people-with-ms/

Related News

MS News

Thank you! Ocrevus and Kesimpta will remain on the PBS

17 July 2026

The Australian Government has confirmed that Ocrevus and Kesimpta will remain available through the Pharmaceutical Benefits Scheme (PBS), meaning thousands of Australians living with MS can continue to access these life-changing treatments. 

MS News

MS Australia applauds Health Minister’s announcement that Ocrevus and Kesimpta will remain on the PBS

16 July 2026

MS Australia warmly welcomes the announcement from the Minister for Health and Aged Care, the Hon Mark Butler MP, that Ocrevus (ocrelizumab) and Kesimpta (ofatumumab) will remain available through the Pharmaceutical Benefits Scheme (PBS).

MS News

PBS access to two vital MS treatments under threat as Government decision looms

1 July 2026

Multiple disease-modifying therapies (DMTs), Ocrevus (ocrelizumab) and Kesimpta (ofatumumab), are at risk of being withdrawn from the Pharmaceutical Benefits Scheme (PBS), as a consequence of government-driven policy-related price reductions.

Read More
lifestyle guide for MSlifestyle factors - supplements and gut health

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Modifiable Lifestyle Factors: Lipid Levels